A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications.
Adult
Animals
Cardiovascular Diseases
/ complications
Cytokines
/ blood
Diabetes Mellitus, Type 2
/ pathology
Diabetic Retinopathy
/ pathology
Female
Humans
Insulin Resistance
/ physiology
Male
Metabolic Syndrome
/ pathology
Mice
Middle Aged
Th1 Cells
/ immunology
Th1-Th2 Balance
/ physiology
Th2 Cells
/ immunology
Inflammation
Insulin resistance
Metabolic syndrome
Th1/Th2 cytokines
Type 2 diabetes mellitus
Journal
Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
30
05
2019
revised:
09
09
2019
accepted:
14
10
2019
pubmed:
11
11
2019
medline:
30
6
2021
entrez:
10
11
2019
Statut:
ppublish
Résumé
The T-helper (Th1/Th2) paradigm is widely studied for its role in modulating an adaptive immune response, especially in relation to the onset of various autoimmune diseases. In fact, emerging evidence clearly shows an inverse relationship between Th1/Th2 cytokines and the development of type 2 diabetes (T2D) complications, which is accelerated by an exacerbated inflammatory state. Here, relevant studies reporting on any association between the levels of Th1/Th2 cytokines and the development of T2D were retrieved through major electronic databases such as The Cochrane Library, Embase and PubMed. Extracted evidence which mostly involved animal models and human subjects with T2D or metabolic syndrome was assessed for quality and risk of bias using the Downs and Black checklist and Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Results strongly correlated raised Th1/Th2 cytokines such as interferon-gamma (IFN-γ)/interleukin (IL)-5 and IL-2/IL-5 ratios to T2D, and this was positively linked with the other complications including retinopathy and cardiovascular complications. Further, logistic regression analysis demonstrated that the Th1/Th2 ratios were significantly associated with impaired glucose homeostasis, abnormally enhanced lipid profiles, and insulin resistance. Although more studies making use of a larger sample size are required, current data suggest that optimal modulation of Th1/Th2 cytokines may be an important aspect in the management of T2D and its associated complications.
Identifiants
pubmed: 31704479
pii: S1043-4666(19)30321-7
doi: 10.1016/j.cyto.2019.154892
pii:
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
154892Subventions
Organisme : FIC NIH HHS
ID : D43 TW010131
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.